Ioannis Stefanidis

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 589 citations · Full text

Urology, Renal Disease, Renal Events +7

Imaging Modalities for Renal Artery Stenosis in Suspected Renovascular Hypertension: Prospective Intraindividual Comparison of Color Doppler US, CT Angiography, GD-Enhanced MR Angiography, and Digital Substraction Angiography

Christos Rountas, Marianna Vlychou, Katerina Vassiou et al. · Renal Failure · 2007 · 183 citations · Full text

Hypertension, Renal Pathology, Renal Artery Stenosis +17

Effect of exercise training and dopamine agonists in patients with uremic restless legs syndrome: a six-month randomized, partially double-blind, placebo-controlled comparative study

Christoforos D. Giannaki, Giorgos K. Sakkas, Christina Karatzaferi et al. · BMC Nephrology · 2013 · 139 citations · Full text

A single-blind randomized controlled trial to evaluate the effect of 6 months of progressive aerobic exercise training in patients with uraemic restless legs syndrome

Christoforos D. Giannaki, Georgios M. Hadjigeorgiou, Christina Karatzaferi et al. · Nephrology Dialysis Transplantation · 2013 · 124 citations

Neutrophil gelatinase-associated lipocalin (NGAL) in inflammatory bowel disease: association with pathophysiology of inflammation, established markers, and disease activity

Kostas Oikonomou, Andreas Kapsoritakis, Catherine T Theodoridou et al. · Journal of Gastroenterology · 2011 · 123 citations

Inflammation, Anti-inflammatory, Autoimmune Disease +11